Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 34,264 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke. DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.
What this blog is for:
My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
Showing posts with label INR. Show all posts
Showing posts with label INR. Show all posts
Friday, February 5, 2021
Tuesday, December 24, 2019
NUS researchers develop microsensor implants smaller than a pencil tip for round-the-clock health monitoring
And if we had even two neurons to rub together in our fucking failures of stroke associations they would recognize and create innovation on top of this to measure INR and the correct level of blood clotting when taking aspirin. To send an emergency notification that the levels in the blood aren't correct and need immediate attention. But nothing will occur. It is not their job to solve stroke, I don't know what fucking purpose they do have but it is not to solve stroke and help survivors recover.
NUS researchers develop microsensor implants smaller than a pencil tip forround-the-clock health monitoring
Tiny subcutaneous implants that can
continuously measure a person’s blood glucose, heart rate, and other
physiological conditions are a Holy Grail of modern medicine. A team of
researchers from the National University of Singapore (NUS) has recently
made a quantum leap into turning this dream closer to reality. They
developed a new wireless reader that is so sensitive to minute changes
in a sensor’s readings that it enables the creation of sub-millimetre
microsensors, tiny enough to be injected under the skin.
The team developed a working prototype of the reader that can read a microsensor that is 0.9 millimetres in diameter while implanted underneath the skin using a syringe. In lab experiments, the reader was able to monitor the rate of breathing and heart rate by detecting subtle movements of the battery-free microsensor.
It took two years of research by the team, from February 2017 to January 2019, to develop this innovative microsensor. The team’s achievement was published in August 2019 in the scientific journal Nature Electronics.
“We hope that our breakthrough will be a trailblazer for the future of minimally invasive health monitoring solutions where patients are immediately alerted whenever their physiological conditions such as heart rate and blood glucose cross a critical threshold,” said Asst Prof Ho.
“Now that we have proven the viability of our reader, the next step is to develop a suite of passive (battery-free) microsensors that can monitor various physiological parameters such as glucose, bioelectrical activity and blood chemistry,” he added.
Tuesday, July 23, 2019
Probable Interaction Between Warfarin and Inhaled and Oral Administration of Cannabis
Since your doctor will never recommend cannabis and you will never listen to me, this problem will never occur in you. It might occur in me but that will be my choice.
My 13 reasons for marijuana use post-stroke.
Don't follow me, I'm not medically trained and I don't have a Dr. in front of my name.
Probable Interaction Between Warfarin and Inhaled and Oral Administration of Cannabis
Amy Hsu PharmD, Nathan A. Painter, PharmD, CDE, FAADE

Thursday, October 12, 2017
Smart Tattoo Monitors Health
Could this be used along Needle free blood draws or microneedles to monitor INR for warfarin use instead of having to come in for blood draws? We'll never know with our incompetent stroke leadership.
Smart Tattoo Monitors Health
Checking vital health statistics may someday be as simple as shinning a light on a tattoo.
A group of researchers from Harvard Medical School (HMS) and the Massachusetts Institute of Technology (MIT) have developed a smart tattoo ink that changes color to signal changes in various biomarkers, including if an athlete is dehydrated or if a diabetic’s blood sugar rises.
The researchers paired biosensitive inks with traditional tattoo artistry as a way to overcome some of the limitations of biomedical monitoring devices that currently do not seamlessly integrate with the body.
“We were thinking: New technologies, what is the next generation after wearables?” Ali Yetisen, who is a Tosteson postdoctoral fellow at HMS and Massachusetts General Hospital, said in a statement. “And so we came up with the idea that we could incorporate biosensors in the skin.”
The stabilizing ink does not fade or diffuse into surrounding tissue and only changes color according to the chemistry of the body’s interstitial fluid—which can be used as a surrogate for constituents of the blood.
The researchers developed a pair of inks that signify glucose concentration and sodium concentration.
The first ink will change from green to brown as glucose concentration increases, while the second ink grows a more intense green color when viewed under a blue light as sodium concentration rises, an indication of dehydration.
To test the inks, the researchers tattooed segments of pig skin and found the changes in color or intensity in response to different biomarkers.
The next step will be to test the tattoos with other diseases and biomarkers.
The researchers said a long-lasting tattoo could be used to monitor chronic conditions or a temporary design could be used for shorter-duration monitoring.
The ink can also be invisible and only viewable under certain kinds of light that may be available through a smartphone application.
A group of researchers from Harvard Medical School (HMS) and the Massachusetts Institute of Technology (MIT) have developed a smart tattoo ink that changes color to signal changes in various biomarkers, including if an athlete is dehydrated or if a diabetic’s blood sugar rises.
The researchers paired biosensitive inks with traditional tattoo artistry as a way to overcome some of the limitations of biomedical monitoring devices that currently do not seamlessly integrate with the body.
“We were thinking: New technologies, what is the next generation after wearables?” Ali Yetisen, who is a Tosteson postdoctoral fellow at HMS and Massachusetts General Hospital, said in a statement. “And so we came up with the idea that we could incorporate biosensors in the skin.”
The stabilizing ink does not fade or diffuse into surrounding tissue and only changes color according to the chemistry of the body’s interstitial fluid—which can be used as a surrogate for constituents of the blood.
The researchers developed a pair of inks that signify glucose concentration and sodium concentration.
The first ink will change from green to brown as glucose concentration increases, while the second ink grows a more intense green color when viewed under a blue light as sodium concentration rises, an indication of dehydration.
To test the inks, the researchers tattooed segments of pig skin and found the changes in color or intensity in response to different biomarkers.
The next step will be to test the tattoos with other diseases and biomarkers.
The researchers said a long-lasting tattoo could be used to monitor chronic conditions or a temporary design could be used for shorter-duration monitoring.
The ink can also be invisible and only viewable under certain kinds of light that may be available through a smartphone application.
Saturday, January 7, 2017
Skin patch with microneedles proves effective alternative to injections
With just a bit of innovation this could be used to monitor INR levels and not need to go to the clinic to get a blood draw. A great stroke association would direct some of their employees to solve this rather than waiting for SOMEONE ELSE TO SOLVE THE PROBLEM. A few patents like this could provide a continuing stream of money to fund research. But that will never occur with the fucking failures of stroke associations we have now.
https://www.mdlinx.com/internal-medicine/top-medical-news/article/2017/01/04/5
https://www.mdlinx.com/internal-medicine/top-medical-news/article/2017/01/04/5
KTH Royal Institute of Technology News
It’s
only a matter of time before drugs are administered via patches with
painless microneedles instead of unpleasant injections. But designers
need to balance the need for flexible, comfortable–to–wear material with
effective microneedle penetration of the skin. Researchers from KTH
Royal Institute of Technology in Stockholm say they may have cracked the
problem.
In a study the research team from KTH reports a successful test of its microneedle patch, which combines stainless steel needles embedded in a soft polymer base – the first such combination believed to be scientifically studied. The soft material makes it comfortable to wear, while the stiff needles ensure reliable skin penetration.
Unlike epidermal patches, microneedles penetrate the upper layer of the skin, just enough to avoid touching the nerves. This enables delivery of drugs, extraction of physiological signals for fitness monitoring devices, extracting body fluids for real–time monitoring of glucose, pH level and other diagnostic markers, as well as skin treatments in cosmetics and bioelectric treatments.
Frank Niklaus, professor of micro and nanofabrication at KTH, says that practically all microneedle arrays being tested today are “monoliths”, that is, the needles and their supporting base are made of the same – often hard and stiff – material. While that allows the microneedles to penetrate the skin, they are uncomfortable to wear. On the other hand, if the whole array is made from softer materials, they may fit more comfortably, but soft needles are less reliable for penetrating the skin.
“To the best of our knowledge, flexible and stretchable patches with arrays of sharp and stiff microneedles have not been demonstrated to date,” he says.
They actually tested two variations of their concept, one which was stretchable and slightly more flexible than the other. The more flexible patch, which has a base of molded thiol–ene–epoxy–based thermoset film, conformed well to deformations of the skin surface and each of the 50 needles penetrated the skin during a 30 minute test.
A successful microneedle product could have major implications for health care delivery. “The chronically ill would not have to take daily injections,” says co–author Niclas Roxhed, who is research leader at the Department of Micro and Nano Systems at KTH.
In addition to addressing people’s reluctance to take painful shots, microneedles also offer a hygiene benefit. The World Health Organization estimates that about 1.3 million people die worldwide each year due to improper handling of needles.
“Since the patch does not enter the bloodstream, there is less risk of spreading infections,” Roxhed says.
The report, Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing, was published in the journal PLOS ONE.
In a study the research team from KTH reports a successful test of its microneedle patch, which combines stainless steel needles embedded in a soft polymer base – the first such combination believed to be scientifically studied. The soft material makes it comfortable to wear, while the stiff needles ensure reliable skin penetration.
Unlike epidermal patches, microneedles penetrate the upper layer of the skin, just enough to avoid touching the nerves. This enables delivery of drugs, extraction of physiological signals for fitness monitoring devices, extracting body fluids for real–time monitoring of glucose, pH level and other diagnostic markers, as well as skin treatments in cosmetics and bioelectric treatments.
Frank Niklaus, professor of micro and nanofabrication at KTH, says that practically all microneedle arrays being tested today are “monoliths”, that is, the needles and their supporting base are made of the same – often hard and stiff – material. While that allows the microneedles to penetrate the skin, they are uncomfortable to wear. On the other hand, if the whole array is made from softer materials, they may fit more comfortably, but soft needles are less reliable for penetrating the skin.
“To the best of our knowledge, flexible and stretchable patches with arrays of sharp and stiff microneedles have not been demonstrated to date,” he says.
They actually tested two variations of their concept, one which was stretchable and slightly more flexible than the other. The more flexible patch, which has a base of molded thiol–ene–epoxy–based thermoset film, conformed well to deformations of the skin surface and each of the 50 needles penetrated the skin during a 30 minute test.
A successful microneedle product could have major implications for health care delivery. “The chronically ill would not have to take daily injections,” says co–author Niclas Roxhed, who is research leader at the Department of Micro and Nano Systems at KTH.
In addition to addressing people’s reluctance to take painful shots, microneedles also offer a hygiene benefit. The World Health Organization estimates that about 1.3 million people die worldwide each year due to improper handling of needles.
“Since the patch does not enter the bloodstream, there is less risk of spreading infections,” Roxhed says.
The report, Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing, was published in the journal PLOS ONE.
Wednesday, August 3, 2016
E-Skin Patch Accurately Tracks Blood-Alcohol Levels
What else could it track with some innovative thinking from our great stroke association? INR testing? Blood pressure? Blood oxygen levels? Stroke in progress?
E-Skin Patch Accurately Tracks Blood-Alcohol Levels
A new type of temporary tattoo could potentially prevent drunk driving accidents in the future.
Engineers from the University of California, San Diego designed an electronic wearable patch that can measure an individual’s blood alcohol level through sensible sweat, the visible form of perspiration that could provide a better real-time indicator of a person’s blood alcohol concentration.
The invention is comprised of screen-printed electrodes, a miniature hydrogel patch housing a sweat-inducing drug called pilocarpine, as well as a flexible electronic circuit board that simultaneously powers the tattoo and enables wireless communication with a mobile device.
“Lots of accidents on the road are caused by drunk driving. This technology provides an accurate, convenient and quick way to monitor alcohol consumption to help prevent people from driving while intoxicated,” said nanoengineering professor Joseph Wang, one of the co-leaders of this experiment, in a statement.
Please follow R&D Magazine on LinkedIn
It was tested on nine healthy volunteers where it was attached to their arms after drinking either a bottle of beer or a glass of red wine, according to the university’s announcement.
The process begins when the tattoo discharges the pilocarpine to make the wearer sweat. An electrode coated in the alcohol oxidase enzyme will react by generating hydrogen peroxide upon coming into contact with the individual’s perspiration.
Hydrogen peroxide can be detected electrochemically so that information is transformed into electrical signals sent wirelessly to a mobile device through Bluetooth, per the university’s press release.
It took about 15 minutes for the tattoo to deliver results. The accuracy of the results remained intact after numerous attempts at bending and shaking the tattoo emphasizing read-outs won’t be impaired by movement.
Wang suggested that this technology could eventually be built into a car’s alcohol ignition locks, but his team’s next steps will be designing a device that may be able to monitor alcohol levels for a full 24 hours.
Another organization is developing an alternative method for tracking blood alcohol levels with a slight tweak.
San, Francisco-based BACtrack won a $200,000 grand prize in May for its prototype wrist monitor named BACtrack Skyn. This device measures the ethanol seeping through a person’s skin in order to determine how much they’ve had to drink, but takes 45 minutes to completely analyze the information it’s given.
Engineers from the University of California, San Diego designed an electronic wearable patch that can measure an individual’s blood alcohol level through sensible sweat, the visible form of perspiration that could provide a better real-time indicator of a person’s blood alcohol concentration.
The invention is comprised of screen-printed electrodes, a miniature hydrogel patch housing a sweat-inducing drug called pilocarpine, as well as a flexible electronic circuit board that simultaneously powers the tattoo and enables wireless communication with a mobile device.
“Lots of accidents on the road are caused by drunk driving. This technology provides an accurate, convenient and quick way to monitor alcohol consumption to help prevent people from driving while intoxicated,” said nanoengineering professor Joseph Wang, one of the co-leaders of this experiment, in a statement.
Please follow R&D Magazine on LinkedIn
It was tested on nine healthy volunteers where it was attached to their arms after drinking either a bottle of beer or a glass of red wine, according to the university’s announcement.
The process begins when the tattoo discharges the pilocarpine to make the wearer sweat. An electrode coated in the alcohol oxidase enzyme will react by generating hydrogen peroxide upon coming into contact with the individual’s perspiration.
Hydrogen peroxide can be detected electrochemically so that information is transformed into electrical signals sent wirelessly to a mobile device through Bluetooth, per the university’s press release.
It took about 15 minutes for the tattoo to deliver results. The accuracy of the results remained intact after numerous attempts at bending and shaking the tattoo emphasizing read-outs won’t be impaired by movement.
Wang suggested that this technology could eventually be built into a car’s alcohol ignition locks, but his team’s next steps will be designing a device that may be able to monitor alcohol levels for a full 24 hours.
Another organization is developing an alternative method for tracking blood alcohol levels with a slight tweak.
San, Francisco-based BACtrack won a $200,000 grand prize in May for its prototype wrist monitor named BACtrack Skyn. This device measures the ethanol seeping through a person’s skin in order to determine how much they’ve had to drink, but takes 45 minutes to completely analyze the information it’s given.
Tuesday, July 19, 2016
Fluctuations in “bad” cholesterol may be linked to worse brain health
How would your doctor even know if this is happening to you? While INR testing does not necessarily require fasting anymore, I'm sure frequent blood draws for this would not be covered by insurance. Unless the needle free blood draws come into practice soon.
http://www.alphagalileo.org/ViewItem.aspx?ItemId=166067&CultureCode=en
Greater fluctuations in “bad” cholesterol levels may be linked to worse cognitive function in elderly adults, according to new research in the American Heart Association’s journal Circulation.
In a study of European adults age 70 to 82 years old, researchers found that greater fluctuations in low-density lipoprotein cholesterol (LDL), or “bad” cholesterol, are associated with lower cognitive performance.
For example, study participants with the highest LDL cholesterol variability took 2.7 seconds longer on average to finish a cognitive test to name ink colors of color words written in different ink (for example, the word blue written in red ink), compared to individuals with the lowest variability.
“While this might seem like a small effect, it is significant at a population level,” said Roelof Smit, M.D., lead study author and a Ph.D. student at Leiden University Medical Center in Leiden, the Netherlands.
The link between variability and declining cognitive function was found regardless of average bad cholesterol levels or use of cholesterol-lowering statin drugs.
In addition, greater fluctuations in bad cholesterol were associated with lower brain blood flow and greater white matter hyperintensity load - which has been linked to endothelialdysfunction.
These results show LDL cholesterol variability may be important to neurocognitive function, Smit said.
“Our findings suggest for the first time that it’s not just the average level of your LDL-cholesterol that is related to brain health, but also how much your levels vary from one measurement to another,” Smit said.
Measurements fluctuate because of diet, exercise, frequency of cholesterol-lowering statins and other factors, he said. However, these fluctuations might also reflect an increasingly impaired homeostasis; for example, due to age or underlying disease, added J.Wouter Jukema, M.D., Ph.D., senior author of the study and professor of Cardiology at the Leiden University Medical Center.
The research involved 4,428 participants from Scotland, Ireland and the Netherlands in the PROspective Study of Pravastatin in the Elderly at Risk. PROSPER participants either had preexisting vascular disease or were at a higher risk for developing the condition because of histories of hypertension, cigarette smoking or diabetes.
Researchers examined associations between LDL cholesterol variability and four cognitive measures: color-word test for selective attention, letter-digit coding to assess information processing speed and picture-word learning to test verbal memory in two ways – immediate recall and delayed recall after 20 minutes.
Although the research population was European, the results may be applicable to Americans as their lifestyle patterns predispose them to the same set of clinical outcomes, Smit said. But the results cannot be extrapolated directly to the general U.S. population because the study participants were older adults at high risk for vascular disease.
“These results add an important puzzle piece to the emerging evidence that vascular risk factors are closely related to brain health,” Smit said. “Our study is just the first exciting step. Further studies are needed to examine whether these findings could truly influence clinical practice.”
http://newsroom.heart.org/news/fluctuations-in-bad-cholesterol-may-be-linked-to-worse-brain-health?preview=c778cef4bfb05954aef5021158d0a591
http://www.alphagalileo.org/ViewItem.aspx?ItemId=166067&CultureCode=en
Greater fluctuations in “bad” cholesterol levels may be linked to worse cognitive function in elderly adults, according to new research in the American Heart Association’s journal Circulation.
In a study of European adults age 70 to 82 years old, researchers found that greater fluctuations in low-density lipoprotein cholesterol (LDL), or “bad” cholesterol, are associated with lower cognitive performance.
For example, study participants with the highest LDL cholesterol variability took 2.7 seconds longer on average to finish a cognitive test to name ink colors of color words written in different ink (for example, the word blue written in red ink), compared to individuals with the lowest variability.
“While this might seem like a small effect, it is significant at a population level,” said Roelof Smit, M.D., lead study author and a Ph.D. student at Leiden University Medical Center in Leiden, the Netherlands.
The link between variability and declining cognitive function was found regardless of average bad cholesterol levels or use of cholesterol-lowering statin drugs.
In addition, greater fluctuations in bad cholesterol were associated with lower brain blood flow and greater white matter hyperintensity load - which has been linked to endothelialdysfunction.
These results show LDL cholesterol variability may be important to neurocognitive function, Smit said.
“Our findings suggest for the first time that it’s not just the average level of your LDL-cholesterol that is related to brain health, but also how much your levels vary from one measurement to another,” Smit said.
Measurements fluctuate because of diet, exercise, frequency of cholesterol-lowering statins and other factors, he said. However, these fluctuations might also reflect an increasingly impaired homeostasis; for example, due to age or underlying disease, added J.Wouter Jukema, M.D., Ph.D., senior author of the study and professor of Cardiology at the Leiden University Medical Center.
The research involved 4,428 participants from Scotland, Ireland and the Netherlands in the PROspective Study of Pravastatin in the Elderly at Risk. PROSPER participants either had preexisting vascular disease or were at a higher risk for developing the condition because of histories of hypertension, cigarette smoking or diabetes.
Researchers examined associations between LDL cholesterol variability and four cognitive measures: color-word test for selective attention, letter-digit coding to assess information processing speed and picture-word learning to test verbal memory in two ways – immediate recall and delayed recall after 20 minutes.
Although the research population was European, the results may be applicable to Americans as their lifestyle patterns predispose them to the same set of clinical outcomes, Smit said. But the results cannot be extrapolated directly to the general U.S. population because the study participants were older adults at high risk for vascular disease.
“These results add an important puzzle piece to the emerging evidence that vascular risk factors are closely related to brain health,” Smit said. “Our study is just the first exciting step. Further studies are needed to examine whether these findings could truly influence clinical practice.”
http://newsroom.heart.org/news/fluctuations-in-bad-cholesterol-may-be-linked-to-worse-brain-health?preview=c778cef4bfb05954aef5021158d0a591
- Full bibliographic informationStella Trompet, Ph.D.; Behnam Sabayan, M.D., Ph.D.; Saskia le Cessie, Ph.D.; Jeroen van der Grond, Ph.D.; Mark van Buchem, M.D., Ph.D.; Anton de Craen, Ph.D.; and J. Wouter Jukema, M.D., Ph.D. Author disclosures are on the manuscript.; Higher Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability Is Associated With Lower Cognitive Performance, Lower Cerebral Blood Flow, and Greater White Matter Hyperintensity Load in Older Subjects; DOI: 10.1161/CIRCULATIONAHA.115.020627
Sunday, June 19, 2016
Farewell to the fasting cholesterol test?
My doctor still does the fasting one, does yours?
Farewell to the fasting cholesterol test?
Tuesday, May 31, 2016
Velano Vascular needle-free blood draw device
How long before your hospital get this for those damned INR draws? Will you be able to sleep thru the 7am blood draws with this?
http://www.mdlinx.com/internal-medicine/product-center/medical-device-description.cfm/8922/?featured=no
http://www.mdlinx.com/internal-medicine/product-center/medical-device-description.cfm/8922/?featured=no
New device reduces risks, anxiety associated with blood draws
Velano Vascular —Visit Website
The FDA has granted clearance to a modified version of Velano Vascular’s
novel, needle-free blood draw device, which is designed to reduce blood
draw-related discomfort and anxiety for hospital inpatients, provide a
safer work environment for healthcare providers, and standardize today’s
fragmented approaches to inpatient blood draws. This second FDA
clearance of the device includes two modifications designed to enhance
the product’s usability for inpatient blood draws, one of the most
common medical procedures performed today: The addition of a clamp for
use with syringe draws, a frequent practice in pediatric patients, and a
refinement to the Indication for Use (IFU). The Velano
device is attached to a peripheral IV catheter to draw blood directly
into a vacuum tube or a syringe; the revised IFU removes a limitation in
the earlier clearance that specified when the device could be used with
in-dwelling peripheral IV catheters.
Roughly 760 inpatient blood draws are conducted every minute in the
United States alone. Despite their ubiquity, blood draws create
tremendous disruption for patients and clinicians alike, and are
associated with significant direct and indirect costs. Twenty-eight
percent of adult venipunctures and 44 percent of pediatric venipunctures
require more than one stick to successfully draw blood, and around 10
percent of children aged 3 to 10 years old must be physically restrained
to endure a needle-based blood draw. Published data suggest that U.S.
healthcare professionals endure an average of 200 needle-related
injuries each day. Aside from the significant physical and emotional
toll of these injuries and any related seroconversion, studies suggest
that accidental needle sticks cost hospitals upwards of $50 million per
year.
Tuesday, April 26, 2016
Vein Illuminator Technology for drawing blood
This wuld be great for all those blood draws in testing INR.
https://www.facebook.com/UNILADTech/videos/1709409186003462/?fref=nf
Drawing blood from someone has never been easier with this new technology.
https://www.facebook.com/UNILADTech/videos/1709409186003462/?fref=nf
Drawing blood from someone has never been easier with this new technology.
Wednesday, November 25, 2015
Tech Tats: The Future of Wearables?
I could easily see this being used for stroke survivors, by adding a nano needle patch you should be able to monitor INR and cholesterol levels. A great stroke association would have hundreds of patents supplying money to be used in research. That's if we had any stroke leadership at all. Which we don't.
Tech Tats: The Future of Wearables?
A forlorn girl sits at the bottom of a staircase in her household. An adult comes by with a small plastic case, opening it to reveal a rectangle sheet. The adult applies the sheet to the girl’s arm and holds a cloth over it. The cloth is pulled away and a small circuit board-like array with glowing green dots is stuck to the girl’s deltoid. The adult pulls out her smartphone, where the girl’s vitals are displayed.“Rather than going to the doctor once a year to get your physical, this Tech Tattoo can be something that you just put on your body once a year and it monitors everything that they would do in a physical and sends that to your doctor, and if there’s an issue, they could call you,” said Eric Schneider, a creative technologist with Chaotic Moon, the developer of Tech Tats, in a video.
“It can look at early signs of fever, your vital signs, heartrate, everything that it needs to look at to notify you that you’re getting sick, or your child is getting sick.”
According to Vice’s Motherboard, the tattoo uses electroconductive paint to transfer data from temperature sensors to an ATiny85 microcontroller.
While the focus is currently on the medical field, Schneider floats the idea of using the Tech Tat as a way to revolutionize the banking industry. Rather than carrying wallets around, credit cards and identification information can be stored right on one’s skin.
Speaking with TechCrunch, Chaotic Moon CEO Ben Lamm said, “The future of wearables is biowearables.” He added that the company is in talks with partners to bring Tech Tats to market.
Chaotic Moon is a software company based in Austin, Texas.
Thursday, May 14, 2015
DARPA Takes A Stab At Needle-Free Blood Draws
This would be so great for our INR testing needs. Then I wouldn't have to be woken up at 7am in the hospital for the vampires to take a sample of my blood. But I bet your hospital will not be using this for 40 years.
http://www.forbes.com/sites/robertszczerba/2015/05/13/darpa-takes-a-stab-at-needle-free-blood-draws/
http://www.forbes.com/sites/robertszczerba/2015/05/13/darpa-takes-a-stab-at-needle-free-blood-draws/
Wednesday, July 30, 2014
Smart tattoo sensors
Right now this seems limited but with any decent innovative thinking at all we could use this for stroke. But do you really think the ASA or NSA will take advantage of this to help stroke survivors?
1. Monitor INR levels because of warfarin use.
2. biofeedback on muscle movement.
3. Monitor brain functions after first stroke, send notices of problems to your smartphone and have it call 911.
“Smart Tattoo” Glucose Biosensors and Effect of Coencapsulated Anti-Inflammatory Agents
----------------------------------------------------------------------
Motorola patents e-tattoo that can read your thoughts by listening to unvocalized words in your throatWould this be useful for aphasia?
----------------------------------------------------------------------
‘Smart tattoo’ may replace finger prick for diabetics
INR maybe?
----------------------------------------------------------------------
Sensors with a smile: The smart 'tattoo' that can measure how tired you are
And your doctor could use this to monitor your fatigue and figure out exactly what causes it. Or is your doctor not willing to solve any of your stroke problems?
----------------------------------------------------------------------
Smart skin electronic tattoos the next leap in health tech
This membrane-like patch can be used to monitor body temperature, heartbeat, brain waves, aid muscle movement, and even help heal wounds
Labels:
aphasia,
ASA,
electronic tattoos,
innovation,
INR,
NSA,
sensors
Monday, February 24, 2014
Medical Researchers Use Light to Quickly and Easily Measure Blood’s Clotting Properties
It doesn't say directly but I wonder if this would replace the blood draws for INR.
http://www.biosciencetechnology.com/news/2014/02/medical-researchers-use-light-quickly-and-easily-measure-blood%E2%80%99s-clotting-properties?#.UwvxmIWthEM
http://www.biosciencetechnology.com/news/2014/02/medical-researchers-use-light-quickly-and-easily-measure-blood%E2%80%99s-clotting-properties?#.UwvxmIWthEM
Saturday, March 16, 2013
Wear Your Doctor
The inventors at a Great stroke association would tackle creating an INR tracking device for your warfarin levels so you wouldn't need to go for a blood draw every week. Wearing a electronic bandaid wouldn't be so bad unless you are paranoid about government monitoring. .
http://ideas.time.com/2013/03/14/10-big-ideas/slide/wear-your-doctor/
http://ideas.time.com/2013/03/14/10-big-ideas/slide/wear-your-doctor/
Friday, November 16, 2012
A Bayesian Dose-Individualization Method for Warfarin
For you statistical and probability geeks. In case your doctor is not.
http://adisonline.com/pharmacokinetics/Abstract/publishahead/A_Bayesian_Dose_Individualization_Method_for.99925.aspx
http://adisonline.com/pharmacokinetics/Abstract/publishahead/A_Bayesian_Dose_Individualization_Method_for.99925.aspx
Abstract
Background: Warfarin is a difficult drug to dose
accurately and safely due to large inter-individual variability in dose
requirements. Current dosing strategies appear to be sub-optimal, with
reports indicating that patients achieve international normalized ratios
(INRs) within the therapeutic range only 40-65 % of the time. The
consequences of poor INR control are potentially severe with INRs below 2
carrying an increased risk of clotting while INRs >4 increase the
risk of major bleeding events. Bayesian forecasting methods have the
potential to improve INR control.
Aims: The aims of this study were to (1) prospectively
assess the predictive performance of a Bayesian dosing method for
warfarin implemented in TCIWorks; and (2) determine the expected time in
the therapeutic range (TTR) of INRs predicted using TCIWorks.
Methods: Patients who were initiating warfarin therapy
were prospectively recruited from Dunedin Hospital, Dunedin, New
Zealand. Warfarin doses were entered into TCIWorks from the first day of
therapy until a stable steady-state INR (INRss) was achieved. The
predicted INRss values were determined using the first zero to six
serially collected INR observations. Observed and predicted INRss values
were compared using measures of bias (mean prediction error [MPE]) and
imprecision (root mean square error [RMSE]). The TTR was determined by
calculating the percentage of predicted INRss values between 2 and 3
when zero to six serially collected INR observations were available.
Results: A total of 55 patients were recruited between
March and November 2011. When no observed INR values were available the
resulting INRss predictions were positively biased (MPE 0.52 [95 % CI
0.30, 0.73]); however, this disappeared once observed INR values were
entered into TCIWorks. The precision of the predicted INRss values
improved dramatically once three or more observed INR values were
available (RMSE less than 0.53) compared with no INRs (RMSE 0.96). These
results suggest that TCIWorks will be effective at maintaining the INR
within the therapeutic INR range (2-3) 65 % of the time when three INR
measurements are available and 80 % of the time when six INR
measurements are available.
Conclusion: The TCIWorks warfarin dosing method produced
accurate and precise INRss predictions. We predict that the method will
provide an INR value within the therapeutic range 65-80 % of the time
once three or more INR observations are available, making this a useful
tool for clinicians and warfarin clinics. Further research to assess the
impact of this method on long-term INR control is warranted.
Sunday, August 5, 2012
Warfarin Management International Normalized Ratio Self-Testing and Warfarin Self-Dosing
So it seems self-testing is now possible.
http://circ.ahajournals.org/content/126/5/e52.short
http://circ.ahajournals.org/content/126/5/e52.short
Until recently, most patients taking warfarin (brand name
Coumadin) had to visit a laboratory and/or clinic every few weeks
for an international normalized ratio (INR) blood
test and adjustment of their warfarin dose. It is now possible for a
patient
to measure his/her INR (self-testing) with a
finger-stick drop of blood with use of a small, portable,
battery-powered device.
Some self-testing patients adjust their dose of
warfarin (self-dosing) based on a set of instructions. Even more
recently,
online systems have been developed to facilitate
and improve self-testing and self-dosing. Patients who use self-testing
have
described it as life changing. A video on the ease
and benefits of self-testing by a physician-patient named Dr Michael
Schwartz
can be viewed on ClotCare at
www.clotcare.org/inrselftestingvideo.aspx.
Does Self-Testing Offer Benefits Beyond Ease and Convenience?
Yes. The additional benefits are why
Medicare and other insurance companies started paying for self-testing
for most patients
in March 2008. To understand the other potential
benefits, however, one needs some background information. Warfarin is
used
to prevent blood clots that cause strokes, heart
attacks, or other life-threatening conditions. If the dose of warfarin
is
too small, the INR will be low, and a patient
may get a blood clot. If the dose is too large, the INR will be high,
and a
patient may develop a bleeding problem. In most
cases, an INR between 2 and 3 indicates that the warfarin dose is about
right.
In one large study,1 the risk of stroke caused by a blood clot increased 3 to 4 times when the …
Friday, July 6, 2012
Hemarthrosis in a Patient on Warfarin Receiving Ceftaroline: A Case Report and Brief Review of Cephalosporin Interactions with Warfarin
Another item to talk to your doctor about.
http://www.theannals.com/content/early/2012/07/03/aph.1Q771.abstract
http://www.theannals.com/content/early/2012/07/03/aph.1Q771.abstract
Abstract
OBJECTIVE: To report a possible interaction between warfarin and ceftaroline, resulting in hemarthrosis, and provide readers with an
understanding of mechanisms of interaction between cephalosporins and warfarin.
CASE SUMMARY:
Ceftaroline was prescribed for an 85-year-old female with a therapeutic
international normalized ratio (INR) hospitalized
for
the treatment of cellulitis. She was
subsequently readmitted with shoulder pain and a supra-therapeutic INR.
The patient was
diagnosed with hemarthrosis, presumably related
to elevated INR. Evaluation using the drug interaction probability scale
for
warfarin and ceftaroline yielded a score
consistent with a possible or probable interaction.
DISCUSSION:
Cephalosporins may interact with warfarin through a variety of
mechanisms, including potentiation of hypoprothrombinemia
related to certain side chain groups, inhibition
of P-glycoprotein, or alteration of gastrointestinal flora. All
mechanisms
reported in the medical literature as of April
2012 are briefly examined, but the latter is the most reasonable
mechanism
for a
ceftaroline interaction with warfarin.
CONCLUSIONS: Health care providers should consider closely monitoring patients receiving antibiotics with activity against
Enterobacteriaceae and warfarin, even if no direct mechanism of interaction has been reported. Further research regarding a
ceftaroline-warfarin interaction is warranted.
Monday, April 9, 2012
Cardio Notes: Coumadin Home Testing Viable
I hated having to get my INR levels tested when I was on warfarin(rat poison). I wonder how long before its available.
http://www.medpagetoday.com/Cardiology/Arrhythmias/32085?utm_source=cardiodaily&utm_medium=email&utm_content=aha&utm_campaign=04-09-12&eun=gd3r&userid=424561&email=oc1dean@yahoo.com&mu_id=5523591
http://www.medpagetoday.com/Cardiology/Arrhythmias/32085?utm_source=cardiodaily&utm_medium=email&utm_content=aha&utm_campaign=04-09-12&eun=gd3r&userid=424561&email=oc1dean@yahoo.com&mu_id=5523591
Warfarin Self-Testing Scores Big
Patients on warfarin (Coumadin) who used a self-testing device were able to maintain a high rate of time in target range, a retrospective analysis of the STABLE study found.
Of the nearly 30,000 patients analyzed, the rate of time in target range for those who self-tested weekly was 73%, while the overall rate, which included variable testing, was 69%, according to Jack Ansell, MD, from Lenox Hill Hospital in New York City.
Compared with younger patients (46 to 64 years), older patients (65 to 74 years) had higher a rate of time in target range (67% versus 72%), Ansell reported at the recent American College of Cardiology meeting.
Comparative times in target range from recent large trials evaluating the new oral anticoagulants have included:
- 64% in the RE-LY trial (dabigatran)
- 55% in ROCKET-AF (rivaroxaban)
- 62% in ARISTOTLE (apixaban)
Ansell said that home monitoring achieves better outcomes because it's convenient for patients, the test is consistent, and the immediate awareness of test results empowers patients and enhances compliance.
Three-quarters of the patients in the STABLE study were on warfarin for nonvalvular atrial fibrillation, and these patients had better rates in therapeutic range compared with patients with other indications such as valvular disease alone or with atrial fibrillation and venous thromboembolism. Men had a slight edge over women in percent time in target range (72% versus 66%).Friday, January 27, 2012
Needleless sensor patch aims to replace frequent bloodwork
Now all they have to do is monitor INR readings for those on warfarin and you could have a running tally of it rather than the stupid two week blood draws. And getting cholesterol levels so you could see on a daily basis what your eating habits do.
Does anyone know how to contact Sano to suggest these items?
Needleless sensor patch aims to replace frequent bloodwork
What if people who have a condition that requires frequent bloodwork could have continuous access to their basic metabolic panel readings without ever having to be poked by a needle?
Early-stage startup Sano Intelligence is taking this concept and running with it, developing a transdermal sensor patch that its founders think could continuously monitor metabolic panels and deliver that data to software platforms or mobile devices.
Founded by Raj Gokal and Ashwin Pushpala — and springboarding off a college project Pushpala worked on — Sano Intelligence is hoping to provide digitalized blood chemistry information to patients and providers through a variety of applications. The original idea was intended for use in diabetes patients, but the founders said they have decided instead to focus on less crowded spaces in healthcare.
Gokal and Pushpala will participate in the Rock Health acceleration program this spring.
Subscribe to:
Posts (Atom)
